Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.86 2.55 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

STAAR Surgical Announces Second Quarter 2013 Results Release Date And Conference Call And Webcast



    STAAR Surgical Announces Second Quarter 2013 Results Release Date And
                         Conference Call And Webcast

PR Newswire

MONROVIA, Calif., July 18, 2013

MONROVIA, Calif., July 18, 2013 /PRNewswire/ -- STAAR Surgical Company
(NASDAQ: STAA) today announced that it will release its financial results for
the second quarter ended June 28, 2013 on Wednesday, July 31, 2013 after the
market close.  The Company will host a conference call and webcast on
Wednesday, July 31, 2013 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss
the Company's second quarter results and recent corporate developments. The
dial-in number for the conference call is 877-703-6105 for domestic
participants and 857-244-7304 for international participants, both using the
passcode 23510067.

The Company will also be using slides to illustrate its second quarter results
and operational progress.  The slides and live webcast of the call can be
accessed from the investor relations section of the STAAR website at
www.staar.com.   

A taped replay of the conference call will also be available beginning
approximately one hour after the call's conclusion and will be available for
seven days.  This replay can be accessed by dialing 888-286-8010 for domestic
callers and 617-801-6888 for international callers, both using passcode
40120994  An archived webcast will also be available at www.staar.com.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25
years, designs, develops, manufactures and markets implantable lenses for the
eye and delivery systems therefor. All of these lenses are foldable, which
permits the surgeon to insert them through a small incision. STAAR's lens used
in refractive surgery as an alternative to LASIK is called an Implantable
Collamer® Lens or "ICL." A lens used to replace the natural lens after
cataract surgery is called an intraocular lens or "IOL." Over 350,000 Visian
ICLs have been implanted to date; to learn more about the ICL go to:
www.visianinfo.com. STAAR has approximately 300 full time employees and
markets lenses in over 60 countries. Headquartered in Monrovia, CA, it
manufactures in the following locations: Nidau, Switzerland; Ichikawa City,
Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit
the Company's website at www.staar.com.

Collamer® is the registered trademark for STAAR's proprietary biocompatible
collagen copolymer lens material. 

CONTACT:  Investors                  Media
          EVC Group                  EVC Group
          Leigh Salvo                Chris Gale
          Doug Sherk                 646-201-5431
          415-568-9348

SOURCE STAAR Surgical Company

Website: http://www.staar.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement